Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1955 1
1962 1
1965 1
1966 1
1970 1
1971 1
1976 1
1978 1
1979 1
1980 2
1981 2
1982 3
1983 5
1984 3
1985 8
1986 2
1987 2
1988 2
1989 2
1990 4
1991 5
1992 3
1993 3
1994 1
1995 7
1996 11
1997 2
1998 13
1999 5
2000 3
2001 8
2002 6
2003 6
2004 3
2005 1
2006 4
2007 3
2008 5
2009 2
2010 9
2011 8
2012 4
2013 7
2014 12
2015 10
2016 10
2017 13
2018 6
2019 10
2020 20
2021 24
2022 27
2023 18
2024 14
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

296 results

Results by year

Filters applied: . Clear all
Page 1
CD106 in Tumor-Specific Exhausted CD8+ T Cells Mediates Immunosuppression by Inhibiting TCR Signaling.
Naoi Y, Morinaga T, Nagasaki J, Ariyasu R, Ueda Y, Yamashita K, Zhou W, Kawashima S, Kawase K, Honobe-Tabuchi A, Ohnuma T, Kawamura T, Umeda Y, Kawahara Y, Nakamura Y, Kiniwa Y, Yamasaki O, Fukushima S, Kawazu M, Suzuki Y, Nishikawa H, Hanazawa T, Ando M, Inozume T, Togashi Y. Naoi Y, et al. Among authors: morinaga t. Cancer Res. 2024 Jul 2;84(13):2109-2122. doi: 10.1158/0008-5472.CAN-23-0453. Cancer Res. 2024. PMID: 38635899
PD-1 blockade therapy promotes infiltration of tumor-attacking exhausted T cell clonotypes.
Nagasaki J, Inozume T, Sax N, Ariyasu R, Ishikawa M, Yamashita K, Kawazu M, Ueno T, Irie T, Tanji E, Morinaga T, Honobe A, Ohnuma T, Yoshino M, Iwata T, Kawase K, Sasaki K, Hanazawa T, Kochin V, Kawamura T, Matsue H, Hino M, Mano H, Suzuki Y, Nishikawa H, Togashi Y. Nagasaki J, et al. Among authors: morinaga t. Cell Rep. 2022 Feb 1;38(5):110331. doi: 10.1016/j.celrep.2022.110331. Cell Rep. 2022. PMID: 35108529 Free article.
Carcinoid Heart Disease With Hypoxemia.
Suenaga T, Ishizu K, Nakamura M, Morofuji T, Morinaga T, Hayashi M, Isotani A, Shirai S, Ando K. Suenaga T, et al. Among authors: morinaga t. JACC Case Rep. 2024 Apr 10;29(10):102335. doi: 10.1016/j.jaccas.2024.102335. eCollection 2024 May 15. JACC Case Rep. 2024. PMID: 38623541 Free PMC article.
Development of interpretable machine learning models to predict in-hospital prognosis of acute heart failure patients.
Tanaka M, Kohjitani H, Yamamoto E, Morimoto T, Kato T, Yaku H, Inuzuka Y, Tamaki Y, Ozasa N, Seko Y, Shiba M, Yoshikawa Y, Yamashita Y, Kitai T, Taniguchi R, Iguchi M, Nagao K, Kawai T, Komasa A, Kawase Y, Morinaga T, Toyofuku M, Furukawa Y, Ando K, Kadota K, Sato Y, Kuwahara K, Okuno Y, Kimura T, Ono K; KCHF Study Investigators. Tanaka M, et al. Among authors: morinaga t. ESC Heart Fail. 2024 Oct;11(5):2798-2812. doi: 10.1002/ehf2.14834. Epub 2024 May 15. ESC Heart Fail. 2024. PMID: 38751135 Free PMC article.
Deletion of Pak1 in CD11c-Positive Cells Confers Resistance to Mouse Skin Carcinogenesis.
Okumura K, Morinaga T, Saito M, Tokunaga Y, Otoyama K, Tanaka S, Isogai E, Kawazu M, Togashi Y, Araki K, Wakabayashi Y. Okumura K, et al. Among authors: morinaga t. J Invest Dermatol. 2024 Aug;144(8):1890-1893.e5. doi: 10.1016/j.jid.2024.01.021. Epub 2024 Feb 6. J Invest Dermatol. 2024. PMID: 38325578 No abstract available.
Two brothers with collagenofibrotic glomerulopathy.
Aoki T, Hayashi K, Morinaga T, Tomida H, Hishida M, Yamamoto S, Kajiwara N, Tamai H. Aoki T, et al. Among authors: morinaga t. CEN Case Rep. 2015 May;4(1):85-89. doi: 10.1007/s13730-014-0145-y. Epub 2014 Sep 18. CEN Case Rep. 2015. PMID: 28509277 Free PMC article.
The characteristics and outcomes in patients with acute heart failure who used tolvaptan: from KCHF registry.
Nishikawa R, Kato T, Morimoto T, Yaku H, Inuzuka Y, Tamaki Y, Yamamoto E, Ozasa N, Tada T, Sakamoto H, Seko Y, Shiba M, Yoshikawa Y, Yamashita Y, Kitai T, Taniguchi R, Iguchi M, Nagao K, Kawai T, Komasa A, Kawase Y, Morinaga T, Toyofuku M, Furukawa Y, Ando K, Kadota K, Sato Y, Kuwahara K, Kimura T; KCHF Study Investigators. Nishikawa R, et al. Among authors: morinaga t. ESC Heart Fail. 2023 Oct;10(5):3141-3151. doi: 10.1002/ehf2.14494. Epub 2023 Aug 29. ESC Heart Fail. 2023. PMID: 37644779 Free PMC article.
296 results